CHRONIC GRAFT VERSUS HOST DISEASE
Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for chronic Graft-Versus-Host disease in india
Disease control Not yet recruitingThis study tests the safety of a drug called belumosudil in 26 Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Participants must have tried at least two prior treatments. The study lasts up to 12 months, with 24 w…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Blood test could predict transplant complication years in advance
Knowledge-focused Not yet recruitingThis study looks for proteins in the blood that can help doctors predict if a patient will develop chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Researchers will analyze blood samples from 1500 transplant recipients to build a model that combines these p…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC